AKAkihiro Kondo

Akihiro Kondo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Akihiro Kondo has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Takatoshi Nakagawa

    Department of Glycotherapeutics, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Osaka 565-0871, Japan

    4 shared publications
  • Eiji Miyoshi

    Department of Glycotherapeutics, Department of Functional Diagnostic Science, Division of Health Science, Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Osaka 565-0871, Japan and Department of Disease Glycomics, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan

    3 shared publications
  • Naoyuki Taniguchi

    Department of Glycotherapeutics, Department of Functional Diagnostic Science, Division of Health Science, Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Osaka 565-0871, Japan and Department of Disease Glycomics, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan

    3 shared publications
  • Jinhua Jin

    Departments of Biochemistry , Osaka University Graduate School of Medicine , Osaka 565-0871 , Japan

    2 shared publications
  • Nobuto Koyama

    Takara Bio Inc. Shiga 520-2193 , Japan

    2 shared publications
  • Wenzhe Li

    Department of Glycotherapeutics, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan

    2 shared publications

Latest Publications

  • Glycomic Analysis of Alpha-Fetoprotein L3 in Hepatoma Cell Lines and Hepatocellular Carcinoma Patients

    by Takatoshi Nakagawa, Eiji Miyoshi, Takayuki Yakushijin, Naoki Hiramatsu, Takumi Igura, Norio Hayashi, Naoyuki Taniguchi, Akihiro Kondo

    The N-glycan structures of the Lens culinaris agglutinin (LCA)-reactive fraction of alpha-fetoprotein (AFP-L3), a tumor marker of hepatocellular carcinomas (HCC), were analyzed in relationship to glycosyltransferases and LCA-affinity electrophoresis. Using HPLC and MALDI-TOF MS, we determined the N-glycan structures of AFP from HCC cell lines, and demonstrated they were affected by N-acetylglucosaminyltransferase III and fucosyltransferase VIII, but not by N-acetylglucosaminyltransferase V. Moreover, we identified the N-glycan structures of AFP in HCC patients.


  • S1179 IgG Oligosaccharide Alterations Are a Novel Diagnostic Marker for Disease Activity and the Clinical Course of Inflammatory Bowel Disease

    by Shinichiro Shinzaki, Hideki Iijima, Takatoshi Nakagawa, Satoshi Egawa, Sachiko Nakajima, Jumpei Kondo, Shuji Ishii, Yoshimi Kakiuchi, Tsutomu Nishida, Tatsuya Kanto, et al.

  • Open Access

    Reduced 4 1 Integrin/VCAM-1 Interactions Lead to Impaired Pre-B Cell Repopulation in Alpha 1,6-Fucosyltransferase Deficient Mice

    by Wenzhe Li, Katsuhiko Ishihara, Takafumi Yokota, Takatoshi Nakagawa, Nobuto Koyama, Jinhua Jin, Yoko Mizuno-Horikawa, Xiangchun Wang, Eiji Miyoshi, Naoyuki Taniguchi, et al.

    Mice with a targeted gene disruption of Fut8 (Fut8−/−) showed an abnormality in the transition from pro-B cell to pre-B cell, reduced peripheral B cells, and a decreased immunoglobulin production. Alpha 1,6-fucosyltransferase (FUT8) is responsible for the alpha 1,6 core fucosylation of N-glycans, which could modify the functions of glycoproteins. The loss of a core fucose in both very late antigen 4 (VLA-4, α4β1 integrin) and vascular cell adhesion molecule 1 (VCAM-1) led to a decreased binding between pre-B cells and stromal cells, which impaired pre-B cells generation in Fut8−/− mice. Moreover, the B lineage genes, such as CD79a, CD79b, Ebf1, and Tcfe2a, were downregulated in Fut8−/− pre-B cells. Indeed, the frequency of preBCR+CD79blow cells in bone marrow pre-B cells in Fut8−/− was much lower than that in Fut8+/+ cells. These results reveal a new role of core fucosylated N-glycans in mediating early B cell development and functions.


  • Open Access

    Down-regulation of trypsinogen expression is associated with growth retardation in α1,6-fucosyltransferase-deficient mice: attenuation of proteinase-activated receptor 2 activity

    by Wenzhe Li, Takatoshi Nakagawa, Nobuto Koyama, Xiangchun Wang, Jinhua Jin, Yoko Mizuno-Horikawa, Jianguo Gu, Eiji Miyoshi, Ikunoshin Kato, Koichi Honke, et al.

    Alpha1,6-fucosyltransferase (Fut8) plays important roles in physiological and pathological conditions. Fut8-deficient (Fut8−/−) mice exhibit growth retardation, earlier postnatal death, and emphysema-like phenotype. To investigate the underlying molecular mechanism by which growth retardation occurs, we examined the mRNA expression levels of Fut8−/− embryos (18.5 days postcoitum [dpc]) using a cDNA microarray. The DNA microarray and real-time polymerase chain reaction (PCR) analysis showed that a group of genes, including trypsinogens 4, 7, 8, 11, 16, and 20, were down-regulated in Fut8−/− embryos. Consistently, the expression of trypsinogen proteins was found to be lower in Fut8−/− mice in the duodenum, small intestine, and pancreas. Trypsin, an active form of trypsinogen, regulates cell growth through a G-protein-coupled receptor, the proteinase-activated receptor 2 (PAR-2). In a cell culture system, a Fut8 knockdown mouse pancreatic acinar cell carcinoma, TGP49-Fut8-KDs, showed decreased growth rate, similar to that seen in Fut8−/− mice, and the decreased growth rate was rescued by the application of the PAR-2-activating peptide (SLIGRL-NH2). Moreover, epidermal growth factor (EGF)-induced receptor phosphorylation was attenuated in TGP49-Fut8-KDs, which was highly associated with a reduction of trypsinogens mRNA levels. The addition of exogenous EGF recovered c-fos, c-jun, and trypsinogen mRNA expression in TGP49-Fut8-KDs. Again, the EGF-induced up-regulation of c-fos and c-jun mRNA expression was significantly blocked by the protein kinase C (PKC) inhibitor. Our findings clearly demonstrate a relationship between Fut8 and the regulation of EGF receptor (EGFR)-trypsin-PAR-2 pathway in controlling cell growth and that the EGFR-trypsin-PAR-2 pathway is suppressed in TGP49-Fut8-KDs as well as in Fut8−/− mice.